Judit Nyirady
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Autoimmune Bullous Skin Diseases, Asthma and respiratory diseases
Most-Cited Works
- → The 5-point Investigator’s Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials(2013)253 cited
- → Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials∗(2008)125 cited
- → The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study(2017)110 cited
- → Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs(2011)71 cited
- → Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis(2017)68 cited
- → Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial Skin(2005)62 cited
- → Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial(2017)57 cited
- → The Psoriasis Symptom Diary: development and content validity of a novel patient‐reported outcome instrument(2013)55 cited
- → Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy(2016)55 cited
- → Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomized, double‐blind comparison(2006)43 cited